Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients. [electronic resource]
- British journal of cancer Jun 2002
- 1854-7 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0007-0920
10.1038/sj.bjc.6600413 doi
Acetylcarnitine--therapeutic use Aged Antineoplastic Agents--adverse effects Carnitine--blood Cisplatin--adverse effects Fatigue--chemically induced Female Humans Ifosfamide--adverse effects Male Middle Aged Neoplasms--complications Nootropic Agents--therapeutic use Quality of Life Surveys and Questionnaires Time Factors Treatment Outcome